Signant Health

Signant Health helps clinical trials digitally by enabling a range of tasks during the clinical trial process. The company was founded through a merger between CRF Health and Bracket, both of which were acquired by Genstar Capital.

Signant’s solutions cover patient engagement for electronic consent and simplifying patient tasks, IP management for supply chain management, site enablement for telemedicine and other connectivity solutions, clinical outcome assessments for the collection and analysis of clinical data from patients and sensors, data aggregation for the collection of data from multiple sources, and data analytics for the analysis of clinical data.

The company’s suite of SmartSignals solutions can be customized and selected based on customer requirements and enabled accordingly. Historically, Signant has expanded its product offerings through acquisitions, including ThoughtSphere for data aggregation and analytics as well as VirTrial for site enablement.

In July 2024, the company appointed Paul Richmond as its chief commercial officer. In his new role at Signant Health, Richmond began leading the commercial team and guiding customers in selecting solutions suited to their protocol, disease area, and evidence-generation strategies.

Key customers and partnerships

As of September 2024, the company supported over 600 sponsors and contract research organizations. The company also claims that its customer base includes all top 20 pharmaceutical companies.

In October 2024, the company partnered with SPRIM PRO, a boutique Contract Research Organization (CRO) specializing in biopharmaceutical and nutrition research, to enhance clinical trial technology solutions. Through the partnership, SPRIM PRO began utilizing Signant's SmartSignals Unified Platform, which included EDC, eCOA, eConsent, RTSM, and telemedicine capabilities. 

In September 2024, Signant Health joined IQVIA's One Home for Sites initiative to expand the availability of its eClinical solutions. The partnership allowed Signant's SmartSignals Unified Platform to be accessible through IQVIA's One Home for Sites, a collaborative platform designed for research staff to simplify clinical trial conduct using multiple eClinical technologies. The integration aimed to streamline access to various trial technologies from different providers through a single sign-on system, improving efficiency for clinical research sites.